IL2RG and neoplasm: NVP-LDE-225 was also effective at inhibiting the tumor growth of PC cells in humanized non-obese and diabetic/severe combined immune deficient and IL2 receptor gamma (NOD/SCID IL2Rγ) null mice [50].